Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene

Psychiatry Research

Volumn 113, Issue 1-2, 2002, Pages 49-57

  Rybakowski, Janusz K ^a   Borkowska, Alina ^b   Czerski, Piotr M ^a   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Catechol O methyltransferase; COMT gene; Eye movement disturbances; Gender differences; Prefrontal cortex; Schizophrenia; Val Met polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ENZYME POLYMORPHISM; EYE FIXATION; EYE MOVEMENT CONTROL; EYE MOVEMENT DISORDER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SEX DIFFERENCE; SMOOTH PURSUIT EYE MOVEMENT;

EID: 0037114834     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00245-7     Document Type: Article

References (33)

1. Andreasen N.C., Nopoulos P., O'Leary D.S., Miller D.D., Wassink T., Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biological Psychiatry. 46:1999;908-920.
2. Arolt V., Lencer R., Nolte A., Müller-Myhsok B., Purmann S., Schürmann M., Leutelt J., Pinnow M., Schwinger E. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. American Journal of Medical Genetics. 67:1996;564-579.
3. Arolt V., Lencer R., Purmann S., Schürmann M., Müller-Myhsok B., Krecker K., Schwinger E. Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia. American Journal of Medical Genetics. 88:1999;603-606.
4. Bunney W.E., Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Research Review. 31:2000;138-146.
5. Cohn C.K., Axelrod J. The effect of estradiol on catechol-O-methyltransferase activity in rat liver. Life Sciences. 10:1971;1351-1354.
6. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val 108/158 Met phenotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA. 98:2001;6917-6922.
7. Everett J., Lavoie K., Gagnon J.-F., Gosselin N. Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST). Journal of Psychiatry and Neurosciences. 26:2001;123-130.
8. Faraone S.V., Seidman L.J., Kremen W.S., Pepple J.R., Lyons M.J., Tsuang M.T. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. Journal of Abnormal Psychology. 104:1995;286-304.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. Users Guide for the SCID-I for DSM-IV Axis I Disorders-Research Version. 1996;Biometrics Research, New York State Psychiatric Institute, New York.
10. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences USA. 95:1998;9991-9996.
11. Goldman-Rakic P.S., Muly E.C., Williams G.V. D1 receptors in prefrontal cells and circuits. Brain Research Review. 31:2000;295-301.
12. Hamilton S.P., Slager S.L., Heiman G.A., Deng Z., Haghighi F., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., Knowles J.A. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biological Psychiatry. 51:2002;591-601.
13. Holzman P.S. Eye movements and the search for the essence of schizophrenia. Brain Research Review. 31:2000;350-356.
14. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., Gogos J.A. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proceedings of the National Academy of Sciences USA. 94:1997;4572-4575.
15. Karoum F., Chrapusta S.J., Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Journal of Neurochemistry. 63:1994;972-979.
16. Leboyer M., Bellivier F., Nosten-Bertrand M., Jouvent R., Pauls D., Mallet J. Psychiatric genetics: search for phenotypes. Trends in Neurosciences. 221:1998;103-105.
17. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 6:1996;243-250.
18. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., Liu X., Collier D.A. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genetics. 6:1996;131-133.
19. Li T., Vallada H., Curtis D., Arranz M., Xu K., Cai G., Deng H., Liu J., Murray R., Liu X., Collier D.A. Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics. 7:1997;349-353.
20. Li T., Ball D., Zhao J., Murray R.M., Liu X., Sham P.C., Collier D.A. Family-based linkage disequilibrium mapping using snp marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Molecular Psychiatry. 5:2000;77-84.
21. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Menen K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 34:1995;4202-4210.
22. Miller S.A., Dykaes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 16:1988;1215.
23. Nieman D.H., Bour L.J., Linszen D.H., Goede J., Koelman J.H., Gersons B.P., Ongerborer de Viesser B.W. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology. 54:2000;866-871.
24. Palmatier M.A., Kang A.M., Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biological Psychiatry. 46:1999;557-567.
25. Park S. Association of an oculomotor delayed response task and the Wisconsin Card Sorting Test in schizophrenic patients. International Journal of Psychophysiology. 27:1997;147-151.
26. Puzynski S., Bidzinski A., Mrozek S., Zaluska M. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Acta Psychiatrica Scandinavica. 67:1983;96-100.
27. Rosse R.B., Malhotra A.K., Kim S.Y., Deutsch S.I. Visual fixation deficits and evidence of cognitive impairment in schizophrenia. Biological Psychiatry. 31:1992;412-416.
28. Rybakowski J.K., Borkowska A. Eye tracking abnormalities in schizophrenia during fixation and smooth pursuit task. International Journal of Psychophysiology. 30:1998;171-172.
29. Rybakowski J.K., Borkowska A., Czerski P.M., Hauser J. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Molecular Psychiatry. 6:2001;718-724.
30. Rybakowski, J.K., Borkowska, A., 2002. Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients. Schizophrenia Research. 54, 105-110.
31. Sereno A.B., Holzman P.S. Antisaccades and smooth pursuit eye movements in schizophrenia. Biological Psychiatry. 37:1995;394-401.
32. Van der Does A.J.W., Van den Bosch R.J. What determines Wisconsin Card Sorting Test performance in schizophrenia? Clinical Psychology Review. 12:1992;567-583.
33. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral flow evidence. Archives of General Psychiatry. 43:1986;114-124.